This talk will cover in vivo imaging findings on the nature of the dopaminergic alterations in patients with schizophrenia, recent data in bipolar psychosis, and the effects of antipsychotic treatment on dopamine synthesis capacity. Data on the glutamatergic regulation of this aspect of dopamine function will be presented, as well as new data on cannabinoid receptor alterations in first episode psychosis.